Literature DB >> 19285783

Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer.

Julia Alter1, Charles A Sennoga, D M Lopes, Robert J Eckersley, Dominic J Wells.   

Abstract

In the search for an efficient nonviral gene therapy approach for the treatment of genetic disorders of cardiac and skeletal muscle such as Duchenne muscular dystrophy, ultrasound in combination with contrast enhancing microbubbles has emerged as a promising tool for safe and site-specific enhancement of gene delivery. Indeed, microbubble-enhanced gene transfer (MBGT) has been investigated for a wide variety of target sites using both reporter and therapeutic genes. Although a range of different microbubbles have been used for MBGT studies, comparison of their efficiencies is difficult because microbubble concentration and the ultrasound settings used for the application vary considerably. Only two studies to date have attempted a direct comparison of commercially available microbubbles, and both concluded that not all microbubbles show the same efficiencies with MBGT. Thus far, the reason for this is unclear. Here, the efficiency of three commercially available microbubbles--Optison, SonoVue and Sonazoid--was analyzed to understand the microbubble properties that are important for their function as an effective enhancer for gene transfer in vivo. In this study, plasmid DNA or antisense oligonucleotides were delivered by systemic injection with MBGT, focused on the heart. Gene delivery to the heart with equalized concentrations of the three microbubbles showed that Optison and Sonazoid are more efficient in MBGT compared with SonoVue, which showed the weakest gene transfer to the myocardium. Investigations into the properties of these microbubbles showed that size and shell composition did not directly influence MBGT, whereas the microbubbles with increased stability in an ultrasound field showed better MBGT results than those degrading faster. Moreover, the microbubble concentration used for MBGT was also found to be an important factor influencing the efficiency of MBGT. In conclusion, the stability of a microbubble was shown to be a major influential factor for its performance in MBGT, as is the concentration of the microbubbles used. These findings emphasize the importance of detailed investigations into the properties of microbubbles to allow the production of a microbubble specifically designed for optimum performance with MBGT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285783     DOI: 10.1016/j.ultrasmedbio.2008.12.015

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  15 in total

1.  Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.

Authors:  HaiFang Yin; Amer F Saleh; Corinne Betts; Patrizia Camelliti; Yiqi Seow; Shirin Ashraf; Andrey Arzumanov; Suzan Hammond; Thomas Merritt; Michael J Gait; Matthew Ja Wood
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

Review 2.  The potential of exon skipping for treatment for Duchenne muscular dystrophy.

Authors:  Terence Partridge
Journal:  J Child Neurol       Date:  2010-06-02       Impact factor: 1.987

3.  Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery.

Authors:  Ryan R Sun; Misty L Noble; Samuel S Sun; Shuxian Song; Carol H Miao
Journal:  J Control Release       Date:  2014-03-18       Impact factor: 9.776

4.  Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers.

Authors:  Misty L Noble; Christian S Kuhr; Scott S Graves; Keith R Loeb; Samuel S Sun; George W Keilman; Kyle P Morrison; Marla Paun; Rainer F Storb; Carol H Miao
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

5.  The development of mechanically formed stable nanobubbles intended for sonoporation-mediated gene transfection.

Authors:  Rodi Abdalkader; Shigeru Kawakami; Johan Unga; Yuriko Higuchi; Ryo Suzuki; Kazuo Maruyama; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer.

Authors:  Yunxia Hao; Yan Sun; Yutao Lei; Hongmei Zhao; Ligang Cui
Journal:  Eur Radiol       Date:  2021-01-27       Impact factor: 5.315

7.  Evaluation of methods for sizing and counting of ultrasound contrast agents.

Authors:  Charles A Sennoga; James S M Yeh; Julia Alter; Eleanor Stride; Petros Nihoyannopoulos; John M Seddon; Dorian O Haskard; Joseph V Hajnal; Meng-Xing Tang; Robert J Eckersley
Journal:  Ultrasound Med Biol       Date:  2012-03-06       Impact factor: 2.998

8.  Buoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.

Authors:  Yu-Ren Liou; Yu-Hsin Wang; Chia-Ying Lee; Pai-Chi Li
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 9.  Tissue plasminogen activator-based clot busting: Controlled delivery approaches.

Authors:  Ibrahim M El-Sherbiny; Islam E Elkholi; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

10.  Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency.

Authors:  Cedric M Panje; David S Wang; Marybeth A Pysz; Ramasamy Paulmurugan; Ying Ren; Francois Tranquart; Lu Tian; Jürgen K Willmann
Journal:  Theranostics       Date:  2012-11-08       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.